Nathan Reyelts, PA
Physician Assistant · Fairmont, MNNPI 1932183084
Payments from drug & device makers
Across 78 payments — averaging $15.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$116
- Organogenesis Inc.$83
- Teva Pharmaceuticals USA, Inc.$70
- Corium, LLC$61
- Xeris Pharmaceuticals, Inc.$55
- Grifols USA, LLC$54
- plus $763 from 30 others
What the payments were for
- Food & beverage$1,201100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 8 | $116 |
| Organogenesis Inc. | 5 | $83 |
| Teva Pharmaceuticals USA, Inc. | 4 | $70 |
| Corium, LLC | 5 | $61 |
| Xeris Pharmaceuticals, Inc. | 3 | $55 |
| Grifols USA, LLC | 4 | $54 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $52 |
| Esperion Therapeutics, Inc. | 3 | $52 |
| AbbVie | 3 | $46 |
| Novo Nordisk | 3 | $45 |
| Kowa Pharmaceuticals America, Inc. | 3 | $37 |
| Johnson & Johnson | 2 | $36 |
| AstraZeneca | 2 | $35 |
| Irhythm Technologies, Inc. | 2 | $33 |
| Acadia Pharmaceuticals Inc | 2 | $31 |
| Lundbeck LLC | 2 | $31 |
| Eisai Inc. | 2 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $27 |
| Pfizer | 2 | $26 |
| Boehringer Ingelheim | 2 | $25 |
| Surgenex LLC | 1 | $23 |
| Fresenius Kabi USA, LLC | 1 | $23 |
| Tempus AI, Inc | 1 | $22 |
| Dexcom, Inc. | 1 | $21 |
| Exact Sciences | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Phadia US Inc. | 1 | $16 |
| Abbott | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
| Sanofi | 1 | $14 |
| Radius Health, Inc. | 1 | $14 |
| Bayer | 1 | $13 |
| Novartis | 1 | $11 |
| Itamar Medical Inc | 1 | $10 |
How this compares
$1,201 in reported general payments places this provider in the 90th percentile of 3,121 physician assistant providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 70 | $69,558 |
| JardianceEmpagliflozin | 34 | $41,388 |
| MounjaroTirzepatide | 39 | $41,178 |
| OxycontinOxycodone Hcl | 11 | $36,290 |
| Baclofen | 14 | $35,438 |
| XareltoRivaroxaban | 22 | $32,861 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 37 | $28,730 |
| OzempicSemaglutide | 17 | $23,645 |
| MyrbetriqMirabegron | 38 | $22,681 |
| Victoza 3-PakLiraglutide | 12 | $8,967 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $8,262 |
| KerendiaFinerenone | 12 | $8,174 |
| Liothyronine Sodium | 64 | $4,658 |
| VascepaIcosapent Ethyl | 12 | $3,804 |
| Ventolin HfaAlbuterol Sulfate | 41 | $2,765 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $26 | $69,55870 claims |
| Boehringer IngelheimJardiance | $25 | $41,38834 claims |
| Lilly USA, LLCMounjaro | $16 | $41,17839 claims |
| Johnson & JohnsonXarelto | $36 | $32,86122 claims |
| Novo NordiskOzempic | $45 | $23,64517 claims |
| BayerKerendia | $13 | $8,17412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,121 physician assistant providers in Minnesota.
Other physician assistant in Fairmont
- Sara RobeckBloomington$274K
- Natalie IkemanEdina$170K
- Adam HetzBlaine$156K
- Sarah SchettleRochester$150K
- John IsenbergMaple Grove$92K
- Kenneth MitchellWoodbury$87K
- Jennifer SutherlandMinneapolis$65K
- George FroehleMinneapolis$61K
- Skye PeltierMinneapolis$36K
- Devanie SutterSt Louis Park$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.